"10.1371_journal.pbio.1001199","plos biology","2011-11-15T00:00:00Z","Christopher A Maxwell; Javier Benítez; Laia Gómez-Baldó; Ana Osorio; Núria Bonifaci; Ricardo Fernández-Ramires; Sylvain V Costes; Elisabet Guinó; Helen Chen; Gareth J R Evans; Pooja Mohan; Isabel Català; Anna Petit; Helena Aguilar; Alberto Villanueva; Alvaro Aytes; Jordi Serra-Musach; Gad Rennert; Flavio Lejbkowicz; Paolo Peterlongo; Siranoush Manoukian; Bernard Peissel; Carla B Ripamonti; Bernardo Bonanni; Alessandra Viel; Anna Allavena; Loris Bernard; Paolo Radice; Eitan Friedman; Bella Kaufman; Yael Laitman; Maya Dubrovsky; Roni Milgrom; Anna Jakubowska; Cezary Cybulski; Bohdan Gorski; Katarzyna Jaworska; Katarzyna Durda; Grzegorz Sukiennicki; Jan Lubiński; Yin Yao Shugart; Susan M Domchek; Richard Letrero; Barbara L Weber; Frans B L Hogervorst; Matti A Rookus; J Margriet Collee; Peter Devilee; Marjolijn J Ligtenberg; Rob B van der Luijt; Cora M Aalfs; Quinten Waisfisz; Juul Wijnen; Cornelis E P van Roozendaal; HEBON; EMBRACE; Douglas F Easton; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Patricia Harrington; D Gareth Evans; Fiona Lalloo; Rosalind Eeles; Louise Izatt; Carol Chu; Diana Eccles; Fiona Douglas; Carole Brewer; Heli Nevanlinna; Tuomas Heikkinen; Fergus J Couch; Noralane M Lindor; Xianshu Wang; Andrew K Godwin; Maria A Caligo; Grazia Lombardi; Niklas Loman; Per Karlsson; Hans Ehrencrona; Anna von Wachenfeldt; SWE-BRCA; Rosa Bjork Barkardottir; Ute Hamann; Muhammad U Rashid; Adriana Lasa; Trinidad Caldés; Raquel Andrés; Michael Schmitt; Volker Assmann; Kristen Stevens; Kenneth Offit; João Curado; Hagen Tilgner; Roderic Guigó; Gemma Aiza; Joan Brunet; Joan Castellsagué; Griselda Martrat; Ander Urruticoechea; Ignacio Blanco; Laima Tihomirova; David E Goldgar; Saundra Buys; Esther M John; Alexander Miron; Melissa Southey; Mary B Daly; BCFR; Rita K Schmutzler; Barbara Wappenschmidt; Alfons Meindl; Norbert Arnold; Helmut Deissler; Raymonda Varon-Mateeva; Christian Sutter; Dieter Niederacher; Evgeny Imyamitov; Olga M Sinilnikova; Dominique Stoppa-Lyonne; Sylvie Mazoyer; Carole Verny-Pierre; Laurent Castera; Antoine de Pauw; Yves-Jean Bignon; Nancy Uhrhammer; Jean-Philippe Peyrat; Philippe Vennin; Sandra Fert Ferrer; Marie-Agnès Collonge-Rame; Isabelle Mortemousque; GEMO Study Collaborators; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Sue Healey; kConFab; Mary Helen Barcellos-Hoff; Marc Vidal; Stephen B Gruber; Conxi Lázaro; Gabriel Capellá; Lesley McGuffog; Katherine L Nathanson; Antonis C Antoniou; Georgia Chenevix-Trench; Markus C Fleisch; Víctor Moreno; Miguel Angel Pujana","Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), LHospitalet, Catalonia, Spain; Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain; Biomedical Research Centre Network for Rare Diseases, Spain; Biomedical Research Centre Network for Epidemiology and Public Health, Spain; Biomarkers and Susceptibility Unit, Catalan Institute of Oncology, IDIBELL, LHospitalet, Catalonia, Spain; Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America; Child and Family Research Institute, Vancouver, British Columbia, Canada; Department of Pathology, University Hospital of Bellvitge, IDIBELL, LHospitalet, Catalonia, Spain; CHS National Cancer Control Center, Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, and IFOM Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy; Division of Experimental Oncology 1, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy; Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy; Department of Experimental Oncology, Istituto Europeo di Oncologia, and Consortium for Genomics Technology (Cogentech), Milan, Italy; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel; International Hereditary Cancer Centre, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Unit of Statistical Genetics, Division of Intramural Research Program, National Institute of Mental Health, National Institute of Health, Bethesda, Maryland, United States of America; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America; Family Cancer Clinic, Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Genetics, Rotterdam Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Genetic Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Clinical Molecular Genetics, Utrecht University Medical Center, Utrecht, the Netherlands; Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands; Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands; Department of Clinical Genetics, University Medical Center, Maastricht, the Netherlands; Hereditary Breast and Ovarian Cancer Group, the Netherlands; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom; The Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, United Kingdom; Clinical Genetics, Guys and St. Thomas NHS Foundation Trust, London, United Kingdom; Yorkshire Regional Genetics Service, St. Jamess Hospital, Leeds, United Kingdom; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom; Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Medical Genetics, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America; Section of Genetic Oncology, Department of Oncology, University of Pisa, and Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy; Department of Oncology, Lund University Hospital, Lund, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; Swedish Breast Cancer Study, Sweden; Department of Pathology, Landspitali-University Hospital, Reykjavik, Iceland; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum, Heidelberg, Germany; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum, Heidelberg, Germany, and Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan; Genetic Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain; Molecular Oncology Laboratory, Hospital Clínico San Carlos, Madrid, Spain; Medical Oncology Division, Hospital Clínico de Zaragoza, Zaragoza, Spain; Department of Internal Medicine III, University of Rostock, Rostock, Germany; Center for Experimental Medicine, Institute of Tumor Biology, University Hospital Hamburg–Eppendorf, Hamburg, Germany; Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, United States of America; Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Bioinformatics and Genomics Group, Centre for Genomic Regulation (CRG), Biomedical Research Park of Barcelona (PRBB), Barcelona, Catalonia, Spain; Genetic Counseling and Hereditary Cancer Programme, Catalan Institute of Oncology, IDIBELL and Girona Biomedical Research Institute (IdIBGi), Catalonia, Spain; Latvian Biomedical Research and Study Center, Riga, Latvia; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America; Department of Internal Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, United States of America; Cancer Prevention Institute of California, Fremont, California, United States of America; Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America; Centre for Molecular, Environmental, Genetic and Analytic (MEGA) Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia; Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America; Breast Cancer Family Registry, United States of America; Center for Familial Breast and Ovarian Cancer and Center of Integrated Oncology, University of Cologne, Cologne, Germany; Department of Obstetrics and Gynaecology, Klinikum rechts der Isar, Technical University, Munich, Germany; Division of Oncology, Department of Gynaecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany; Department of Obstetrics and Gynecology, Ulm University, Ulm, Germany; Institut für Humangenetik, Charité-Universitätsmedizin Berlin, Berlin, Germany; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany; Division of Molecular Genetics, Department of Gynaecology and Obstetrics, Clinical Center University of Düsseldorf, Düsseldorf, Germany; N. N. Petrov Institute of Oncology, Saint-Petersburg, Russian Federation; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon, Centre Léon Bérard, Lyon, France; Equipe labellisée LIGUE 2008, UMR5201 CNRS, Centre Léon Bérard, Université de Lyon, Lyon, France; INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris, France; Département dOncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France; Laboratoire dOncologie Moléculaire Humaine, Centre Oscar Lambret, Lille, France; Consultation dOncogénétique, Centre Oscar Lambret, Lille, France; Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France; Service de Génétique-Histologie-Biologie du Développement et de la Reproduction, Centre Hospitalier Universitaire de Besançon, Besançon, France; Service de Génétique, Centre Hospitalier Universitaire Bretonneau, Tours, France; GEMO Study (Genetics Network Groupe Génétique et Cancer), Fédération Nationale des Centres de Lutte Contre le Cancer, France; Queensland Institute of Medical Research, Brisbane, Australia; The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Institute, East Melbourne, Australia; Center for Cancer Systems Biology (CCSB) and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Internal Medicine, Epidemiology, Human Genetics, University of Michigan, Ann Arbor, Michigan, United States of America; Department of Obstetrics and Gynaecologie, Heinrich-Heine-University, Duesseldorf, Germany","The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: CAM J Benitez MAP. Performed the experiments: CAM LG-B AO RF-R SVC HC GJRE PM HA A Villanueva A Aytes GA J Castellsagué DN MCF MAP. Analyzed the data: NB EG IC AP JS-M GR FLejbkowicz RL WLB JCurado HT RG SBG CL LM KLN ACA VM MAP. Contributed reagents/materials/analysis tools: CAM JBenitez AO GR FLejbkowicz PP S Manoukian BP CBR BB A Viel AAllavena LB PR EF BK YL MD RM AJ CCybulski BG KJ KD GS JL YYS SMD RL BLW FBLH MAR JMC PD MJL RBvdL CMA QW JW CEPvR HEBON EMBRACE DFE SP MC CO DF PH DGE FLalloo RE LI CChu DE FD CB HN TH FJC NML XW AKG MAC GL NL PK HE AvW SWE-BRCA RBB UH MUR AL TC RA MS VA KS KO JBrunet GM AU IB LT DEG SB EMJ AM MS MBD BCFR RKS BW AM NA HD RV-M CS DN EI OMS DS-L SMazoyer CV-P LC AdP Y-JB NU J-PP PV SFF M-AC-R IM GEMO ABS JBeesley XC SH kConFab MHB-H MV CL GC LM KLN ACA GC-T MCF VM MAP. Wrote the paper: CAM MAP.","The authors have declared that no competing interests exist.","2011","11","Christopher A Maxwell","CAM",150,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
